Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-Analysis

被引：0
|
作者：
Reginster, Jean Yves [1 ]
Bianic, Florence [2 ]
Campbell, Rosanne [2 ]
Martin, Monique [2 ]
Williams, Setareh A. [3 ]
Fitzpatrick, Lorraine A. [3 ]
机构：
[1] Univ Liege, Liege, Belgium
[2] inVentiv Hlth, London, England
[3] Radius Hlth Inc, Waltham, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2308
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies
    Harris, Steven T.
    Blumentals, William A.
    Miller, Paul D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 237 - 245
  • [22] Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
    Leder, Benjamin Z.
    Mitlak, Bruce
    Hu, Ming-Yi
    Hattersley, Gary
    Bockman, Richard S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 938 - 943
  • [23] The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis
    Xu, Fuxin
    Wang, Yurun
    Zhu, Xinjian
    CLINICAL THERAPEUTICS, 2024, 46 (03) : 267 - 274
  • [24] Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis
    Zhang, Lanling
    Pang, Yafei
    Shi, Yeqing
    Xu, Meijuan
    Xu, Xia
    Zhang, Ju
    Ji, Lianmei
    Zhao, Dongbao
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (09): : 1021 - 1025
  • [25] Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
    Miller, Paul D.
    Hattersley, Gary
    Riis, Bente Juel
    Williams, Gregory C.
    Lau, Edith
    Russo, Luis Augusto
    Alexandersen, Peter
    Zerbini, Cristiano A. F.
    Hu, Ming-yi
    Harris, Alan G.
    Fitzpatrick, Lorraine A.
    Cosman, Felicia
    Christiansen, Claus
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 722 - 733
  • [26] COMPARATIVE EFFECTIVENESS AND SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ren, Y.
    Vyas, A.
    VALUE IN HEALTH, 2024, 27 (06) : S33 - S33
  • [27] Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
    Reginster, JY
    Seeman, E
    De Vernejoul, MC
    Adami, S
    Compston, J
    Phenekos, C
    Devogelaer, JP
    Curiel, MD
    Sawicki, A
    Goemaere, S
    Sorensen, OH
    Felsenberg, D
    Meunier, PJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05): : 2816 - 2822
  • [28] EFFECTS OF ABALOPARATIDE ON VERTEBRAL, NONVERTEBRAL, MAJOR OSTEOPOROTIC AND CLINICAL FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS OF THE PHASE 3 ACTIVE TRIAL
    Fitzpatrick, L. A.
    Miller, P.
    Cosman, F.
    Black, D.
    Lau, E.
    Zerbini, C. A. F.
    Riis, B. J.
    Christiansen, C.
    Williams, G.
    Hu, M. Y.
    Hattersley, G.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S39 - S39
  • [29] Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: Does site-specificity exist?
    Compston, JE
    BONE, 2000, 27 (06) : 765 - 768
  • [30] Denosumab versus Bisphosphonates for Reducing Fractures in Postmenopausal Women with Osteoporosis: A Meta-Analysis
    Thal, Karissa A.
    Nudy, Matthew
    Moser, Eileen M.
    Foy, Andrew J.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2023, 36 (01) : 175 - +
12345